Maria Dêbiec‐Rychter

Also affiliated with KU Leuven

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Supplementary Figure Legend from A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal”.

Supplementary Figure Legend from A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal

Figshare(2023)10.1158/1078-0432.22450700.v1

N/A

0DataRank · unranked

0 citations

Agnieszka Woźniak, Raf Sciot, Haifu Li, Lori S. Friedman, Thomas Van Looy +7 more

Supplementary Figure Legend from A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal

(2023)10.1158/1078-0432.22450700

N/A

0DataRank · unranked

0 citations

Agnieszka Woźniak, Raf Sciot, Haifu Li, Lori S. Friedman, Thomas Van Looy +7 more